Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Factor |
Reference |
Bioavailability |
93.0 |
% |
93 |
% |
PO, oral; |
|
DRUGBANK |
T Max |
2.1 |
h |
0.25-4 |
h |
PO, oral; |
|
DRUGBANK |
Clearance |
5.7 |
L/h |
5.7 |
L/h |
intravenous injection, IV; Single dose; |
|
DRUGBANK |
Clearance |
3.5 |
L/h |
3.49 |
L/h |
moderate hepatic impairment; patients; |
hepatopathy,LD ↓ ; |
DRUGBANK |
Clearance |
0.84 |
L/h |
0.84 |
L/h |
severe hepatic impairment; patients; |
hepatopathy,LD ↓ ; |
DRUGBANK |
Clearance |
0.22 |
L/h/kg |
3.7 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
20.0 |
L |
~20 |
L |
Apparent volume of distribution; |
|
DRUGBANK |
Volume of Distribution |
0.86 |
L/kg |
0.86 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Half-life |
0.17 |
h |
0.17 |
h |
distribution half-life; |
RD, renal impairment, Renal disease,including uremia → ;hyperthyroid, HTh → ; |
DRUGBANK |
Half-life |
5.3 |
h |
5.3 |
h |
elimination half-life; |
|
DRUGBANK |
Half-life |
16.4 |
h |
~16.41 |
h |
|
|
DRUGBANK |
Half-life |
7.1 |
h |
7.1 |
h |
mild hepatic impairment; |
|
DRUGBANK |
Half-life |
22.1 |
h |
22.1 |
h |
severe hepatic impairment; |
|
DRUGBANK |
Half-life |
2.4 |
h |
2.4 |
h |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Toxicity LD50 |
2250.0 |
mg/kg |
2250.0 |
mg/kg |
PO, oral; Rattus, Rat; |
|
DRUGBANK |
Eliminate Route |
3.0 |
% |
~3 |
% |
Faeces excretion; |
|
DRUGBANK |
Eliminate Route |
9.5 |
% |
7-12 |
% |
Urinary excretion; Unchanged drug; |
|
DRUGBANK |
Protein Binding |
0 |
% |
~0 |
% |
|
|
DRUGBANK |